Arvaya Healthcare Ltd

As of June 30, 2026, Arvaya Healthcare Ltd carries a market capitalization of 3.23B, placing it among publicly traded companies globally. Its enterprise value stands at 3.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Arvaya Healthcare Ltd has 48.08M shares outstanding.

As of June 30, 2026, Arvaya Healthcare Ltd trades at a trailing price-to-earnings ratio of 216.87.

As of June 30, 2026, Arvaya Healthcare Ltd trades at an EV/EBITDA multiple of 67.01 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 8.27 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 161.54 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.23B versus a market cap of 3.23B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Arvaya Healthcare Ltd recorded 2.17M in income tax expense. That works out to an effective tax rate of 12.45, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 17.45M, leaving 11.79M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 23, 2026.

Over the twelve months ended June 30, 2026, Arvaya Healthcare Ltd generated 390.20M in revenue and converted that into 11.79M in net income, yielding earnings per share of 0.40. EBITDA reached 48.15M, while operating income came in at 19.97M.

Over the twelve months ended June 30, 2026, Arvaya Healthcare Ltd posted a gross margin of 48.24, reflecting its pricing power and cost economics. The operating margin of 5.12 and net profit margin of 3.02 provide insight into operational efficiency.